All ingredient lists · Model report

Ingredient list

Tirzepatide injection liquid.

Declared composition for LIRAVEXIN catalog number TZP15. This page lists what the catalog names. It is not a laboratory assay and not a test result.

Ingredient list — declared composition, not a test result
GS Laboratory

Prepared as a catalog companion to the model testing report.

Ingredient list

Declared composition for a LIRAVEXIN catalog item — not a tested result

Catalog number
TZP15
Product name
Tirzepatide injection liquid
Labelled amount
15 mg
Pack, as catalogued
15 mg / vial
Physical form
Liquid in a vial, as labelled in the catalog
Catalog
LIRAVEXIN (www.liravexin.com)

Declared ingredients

Ingredient Amount as declared Public identity
Tirzepatide injection liquid15 mgTirzepatide
Tirzepatide presented as an injection liquid according to the catalog. Tirzepatide is a dual GIP and GLP-1 receptor agonist.
Public sequence / structure: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(ε-(AEEA-AEEA-γ-Glu-eicosanedioic acid))-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Other constituents—Not declared on the catalog label. No excipient (for example a bulking agent, counter-ion or residual moisture) is assumed here.

Amino-acid sequences, where shown, are well-known public identities of the named substance. If a sequence could not be stated with confidence, it has been omitted rather than guessed.

Notes

This ingredient list is a declared composition for the catalog item. It is not a Certificate of Analysis and not a statement of purity, identity or content as measured in a laboratory.

The catalog item is a research product, not a medicinal product. This page is not medical advice, not a dosing guide, and not a marketing claim. GS Laboratory does not manufacture or sell peptides or medicines.

Declared composition — not a test result · TZP15